The role of the community pharmacist in fulfilling information needs of patients starting oral antidiabetics

Research in Social and Administrative Pharmacy

Volumn 6, Issue 4, 2010, Pages 354-364

  Lamberts, Egbert J F ^a   Bouvy, Marcel L ^a   van Hulten, Rolf P ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Community pharmacy; Patients' information needs; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT;

AGED; ARTICLE; CLINICAL PRACTICE; FEMALE; GENERAL PRACTITIONER; HUMAN; INFORMATION PROCESSING; MALE; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD;

ADMINISTRATION, ORAL; AGED; COMMUNITY PHARMACY SERVICES; DATA COLLECTION; DIABETES MELLITUS, TYPE 2; FEMALE; FOCUS GROUPS; GENERAL PRACTITIONERS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL ROLE;

EID: 78649467334     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2009.10.002     Document Type: Article

References (35)

1. Wiedenmayer K., Summers R., Mackie C., Gous A., Everard M., Tromp D. Developing Pharmacy Practice. A Focus on Patient Care. Handbook 2006, World Health Organization and International Pharmaceutical Federation, Geneva, Switzerland and The Hague, The Netherlands, pp. 5-8.
2. Latif D.A. Ethical cognition and selection-socialization in retail pharmacy. J Bus Ethics 2000, 25:343-357.
3. Hugtenburg J., Blom A., Kisoensingh S. Initial phase of chronic medication use; patients' reasons for discontinuation. Br J Clin Pharmacol 2006, 61:352-354.
4. Lipscombe L.L., Hux J.E. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: a population-based study. Lancet 2007, 369:750-756.
5. Dekker J.M., van der Kraan M., Nijpels G., et al. Estimate of the number of new patients with type 2 diabetes mellitus in the Netherlands: at least 65,000 per year in the age group of 50 years and above. Ned Tijdschr Geneeskd 2003, 147:1419-1423.
6. Nationaal Kompas Volksgezondheid, (National Public Health Compass), RIVM. Available at: Accessed 29.5.2009. http://www.nationaalkompas.nl.
7. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.
8. Lin E.H., Von Korff M., Katon W., et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995, 33:67-74.
9. Donnan P.T., MacDonald T.M., Morris A.D. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med 2002, 19:279-284.
10. Krapek K., King K., Warren S.S., et al. Medication adherence and associated hemoglobin A1c in type 2 diabetes. Ann Pharmacother 2004, 38:1357-1362.
11. Adherence to Long-Term Therapies Project; Evidence for Action. Geneva, Switzerland: World Health Organization; 2003;13.
12. Cipolle R.J., Strand L.M., Morley P.C. Pharmaceutical Care Practice. The Clinician's Guide 2004, The McGraw-Hill Companies, Inc., New York, NY, 172-174. 2nd ed.
13. Melnyk P.S., Shevchuk Y.M., Remillard A.J. Impact of the dial access drug information service on patient outcome. Ann Pharmacother 2000, 34:585-592.
14. Koo M.M., Krass I., Aslani P. Factors influencing consumer use of written drug information. Ann Pharmacother 2003, 37:259-267.
15. Horne R., Hankins M., Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care 2001, 10:135-140.
16. Kitzinger J. Qualitative research: introducing focus groups. BMJ 1995, 311:299-302.
17. Pope C., Mays N. Reaching the parts other methods cannot reach: an introduction to qualitative methods in health and health services research. BMJ 1995, 311:42-45.
18. Huston S.A., Hobson E.H. Using focus groups to inform pharmacy research. Res Social Adm Pharm 2008, 4:186-205.
19. WHO Collaborating Centre for Drug Statistics Methodology. Norwegian Institute of Public Health. Available at: Accessed 17.03.2009. http://www.whocc.no/atcddd/.
20. Kotler P. Marketing Management, the Millenium Edition 2000, Prentice Hall International, Inc., Upper Saddle River, NJ, pp. 76-8. 5th ed.
21. den Engelsen B., van Beek C., Blijham G. Marketing Voor Zorgverleners 2007, Bohn Stafleu van Loghum, Houten, The Netherlands, pp. 95-96. 1st ed.
22. Campbell S.M., Cantrill J.A. Consensus methods in prescribing research. J Clin Pharm Ther 2001, 26:5-14.
23. Bouma M., Rutten G.E., de Grauw W.J., Wiersma T., Goudswaard A.N. Summary of the practice guideline " diabetes mellitus type 2" (second revision) from the Dutch college of general practitioners. Ned Tijdschr Geneeskd 2006, 50:2251-2256.
24. Hermansen-Kobulnicky C., Worley M. Exploring the patient perspective regarding community pharmacists' educational roles in diabetes medication and blood glucose management. Int J Pharm Pract 2008, 16:81-90.
25. van Mil J.W. Pharmaceutical care in community pharmacy: practice and research in the Netherlands. Ann Pharmacother 2005, 39:1720-1725.
26. Renders C., Valk G., Griffin S., Wagner E., Eijk van J.T., Assendelft W. Interventions to improve the management of diabetes in primary care, outpatient and community settings: a systematic review. Diabetes Care 2001, 24:1821-1833.
27. Griffin S., Kinmonth A. Systems for routine surveillance in people with diabetes mellitus. Cochrane Database Syst Rev 2009, (1). CD000541.
28. Wens J., Vermeire E., Royen P.V., Sabbe B., Denekens J. GPs' perspectives of type 2 diabetes patients' adherence to treatment: a qualitative analysis of barriers and solutions. BMC Fam Pract 2005, 6:20.
29. Cavaco A.M., Dias J.P., Bates I.P. Consumers' perceptions of community pharmacy in Portugal: a qualitative exploratory study. Pharm World Sci 2005, 27:54-60.
30. Traulsen J.M., Almarsdottir A.B., Bjornsdottir I. The lay user perspective on the quality of pharmaceuticals, drug therapy and pharmacy services-results of focus group discussions. Pharm World Sci 2002, 24:196-200.
31. Wermeille J., Bennie M., Brown I., McKnight J. Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team-a pilot study. Pharm World Sci 2004, 26:18-25.
32. Leal S., Glover J.J., Herrier R.N., Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care 2004, 27:2983-2984.
33. Clifford R.M., Davis W.A., Batty K.T., Davis T.M. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2005, 28:771-776.
34. Shojania K.G., Ranji S.R., McDonald K.M., et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006, 296:427-440.
35. Kinnear T.C., Taylor J.R. Marketing Research, an Applied Approach 1996, The McGraw-Hill Companies, Inc, New York, NY, pp. 308-14. 5th ed.